Early Glycosylated Hemoglobin Target Achievement Predicts Clinical Outcomes in Patients with Newly Diagnosed Type 2 Diabetes Mellitus.
作者信息
Lee Joonyub, Cho Jae Hyoung
机构信息
Division of Endocrinology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
出版信息
Diabetes Metab J. 2021 May;45(3):337-338. doi: 10.4093/dmj.2021.0078. Epub 2021 May 25.
Abstract
摘要
相似文献
1
Early Glycosylated Hemoglobin Target Achievement Predicts Clinical Outcomes in Patients with Newly Diagnosed Type 2 Diabetes Mellitus.早期糖化血红蛋白目标达成可预测新诊断2型糖尿病患者的临床结局
Diabetes Metab J. 2021 May;45(3):337-338. doi: 10.4093/dmj.2021.0078. Epub 2021 May 25.
2
Glycosylated hemoglobin levels and new diagnostic criteria.糖化血红蛋白水平与新诊断标准。
Diabetes Care. 1998 Dec;21(12):2198-9. doi: 10.2337/diacare.21.12.2198.
3
Prevalence of prediabetes and newly diagnosed diabetes in patients with a transient ischemic attack or stroke.短暂性脑缺血发作或脑卒中患者中糖尿病前期和新诊断糖尿病的患病率。
Cerebrovasc Dis. 2013;36(4):283-9. doi: 10.1159/000353677. Epub 2013 Oct 16.
4
Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria.空腹血糖与糖化血红蛋白之间的关系：使用新诊断标准对2型糖尿病进行假阳性诊断的可能性。
JAMA. 1999 Apr 7;281(13):1203-10. doi: 10.1001/jama.281.13.1203.
5
The optimal cut-points of HbA₁c for detecting newly diagnosed diabetes and pre-diabetes in the Chinese population living in Sichuan.用于检测居住在四川的中国人群中新诊断糖尿病和糖尿病前期的糖化血红蛋白（HbA₁c）最佳切点
Clin Chem Lab Med. 2011 Oct 18;49(12):2117-8. doi: 10.1515/CCLM.2011.728.
6
[Risk-based prediabetes screening in a rural general practice - oral glucose tolerance test or glycated hemoglobin?].[农村全科医疗中基于风险的糖尿病前期筛查——口服葡萄糖耐量试验还是糖化血红蛋白？]
Orv Hetil. 2019 Dec;160(50):1976-1983. doi: 10.1556/650.2019.31573.
7
8
How to screen NAFLD patients for diabetes?如何对非酒精性脂肪性肝病患者进行糖尿病筛查？
Ann Hepatol. 2016 Sep-Oct;15(5):801-2. doi: 10.5604/16652681.1212621.
9
Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study (Diabetes Metab J 2021;45:368-78).达到目标糖化血红蛋白的时间与新诊断2型糖尿病患者的长期持久血糖控制及糖尿病并发症风险相关：一项6年观察性研究（《糖尿病与代谢杂志》2021年；45:368 - 78）
Diabetes Metab J. 2021 Jul;45(4):617-618. doi: 10.4093/dmj.2021.0152. Epub 2021 Jul 30.
10
Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study (Diabetes Metab J 2021;45:368-78).达到目标糖化血红蛋白的时间与新诊断2型糖尿病患者的长期持久血糖控制及糖尿病并发症风险相关：一项6年观察性研究（《糖尿病与代谢杂志》2021年；45:368 - 78）
Diabetes Metab J. 2021 Jul;45(4):613-614. doi: 10.4093/dmj.2021.0129. Epub 2021 Jul 30.
引用本文的文献
1
Recombinant Hydrophobic Polypeptide MBAY Loaded Into SPION-Exosome Realizes Sustained-Release to Improve Type 2 Diabetes Mellitus.负载于超顺磁性氧化铁纳米颗粒外泌体中的重组疏水多肽MBAY实现缓释以改善2型糖尿病
Drug Des Devel Ther. 2025 Apr 22;19:3103-3118. doi: 10.2147/DDDT.S499641. eCollection 2025.
2
Effects of nurse-led telephone interventions on HbA1c levels in patients with type 2 diabetes: a Meta-analysis-based evaluation of follow-up protocols.护士主导的电话干预对2型糖尿病患者糖化血红蛋白水平的影响：基于Meta分析的随访方案评估
BMC Nurs. 2025 Mar 13;24(1):284. doi: 10.1186/s12912-025-02782-x.
3
Association of long-term visit-to-visit variability of HbA1c and fasting glycemia with hypoglycemia in type 2 diabetes mellitus.HbA1c 和空腹血糖的长期变异性与 2 型糖尿病低血糖的关系。
Front Endocrinol (Lausanne). 2022 Aug 11;13:975468. doi: 10.3389/fendo.2022.975468. eCollection 2022.
4
Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study (Diabetes Metab J 2021;45:368-78).达到目标糖化血红蛋白的时间与新诊断2型糖尿病患者的长期持久血糖控制及糖尿病并发症风险相关：一项6年观察性研究（《糖尿病与代谢杂志》2021年；45:368 - 78）
Diabetes Metab J. 2021 Jul;45(4):617-618. doi: 10.4093/dmj.2021.0152. Epub 2021 Jul 30.
本文引用的文献
1
Durability of Triple Combination Therapy Versus Stepwise Addition Therapy in Patients With New-Onset T2DM: 3-Year Follow-up of EDICT.新诊断 2 型糖尿病患者三联疗法与逐步加药疗法的耐久性比较：EDICT 研究 3 年随访结果
Diabetes Care. 2021 Feb;44(2):433-439. doi: 10.2337/dc20-0978. Epub 2020 Dec 3.
2
Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study.达到目标糖化血红蛋白时间与新诊断 2 型糖尿病患者长期持久血糖控制及糖尿病并发症风险的关系：一项 6 年观察性研究。
Diabetes Metab J. 2021 May;45(3):368-378. doi: 10.4093/dmj.2020.0046. Epub 2020 Oct 20.
3
Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables.基于六个变量的聚类分析：成人发病型糖尿病的新型亚组及其与结局的关系
Lancet Diabetes Endocrinol. 2018 May;6(5):361-369. doi: 10.1016/S2213-8587(18)30051-2. Epub 2018 Mar 5.
4
Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.强化胰岛素治疗对新诊断2型糖尿病患者β细胞功能及血糖控制的影响：一项多中心随机平行组试验
Lancet. 2008 May 24;371(9626):1753-60. doi: 10.1016/S0140-6736(08)60762-X.
5
Effect of a multifactorial intervention on mortality in type 2 diabetes.多因素干预对2型糖尿病患者死亡率的影响。
N Engl J Med. 2008 Feb 7;358(6):580-91. doi: 10.1056/NEJMoa0706245.
6
Diabetes and decline in heart disease mortality in US adults.美国成年人中的糖尿病与心脏病死亡率下降
JAMA. 1999 Apr 14;281(14):1291-7. doi: 10.1001/jama.281.14.1291.
7
Risk factors for diabetic peripheral sensory neuropathy. Results of the Seattle Prospective Diabetic Foot Study.糖尿病周围感觉神经病变的危险因素。西雅图前瞻性糖尿病足研究结果。
Diabetes Care. 1997 Jul;20(7):1162-7. doi: 10.2337/diacare.20.7.1162.
8
The kidney in maturity onset diabetes mellitus: a clinical study of 510 patients.成年型糖尿病患者的肾脏：510例患者的临床研究
Kidney Int. 1982 May;21(5):730-8. doi: 10.1038/ki.1982.90.
9
The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years.威斯康星糖尿病视网膜病变流行病学研究。III. 诊断时年龄为30岁及以上者糖尿病视网膜病变的患病率和风险。
Arch Ophthalmol. 1984 Apr;102(4):527-32. doi: 10.1001/archopht.1984.01040030405011.
Zotero 插件